IHT Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$689K Buy
1,547
+5
+0.3% +$2.23K 0.02% 606
2025
Q1
$747K Sell
1,542
-242
-14% -$117K 0.02% 550
2024
Q4
$718K Sell
1,784
-747
-30% -$301K 0.02% 557
2024
Q3
$1.18M Buy
2,531
+467
+23% +$218K 0.03% 459
2024
Q2
$967K Sell
2,064
-51
-2% -$23.9K 0.04% 445
2024
Q1
$884K Buy
2,115
+337
+19% +$141K 0.04% 464
2023
Q4
$723K Buy
1,778
+36
+2% +$14.6K 0.03% 488
2023
Q3
$606K Sell
1,742
-60
-3% -$20.9K 0.03% 493
2023
Q2
$634K Sell
1,802
-141
-7% -$49.6K 0.03% 470
2023
Q1
$612K Sell
1,943
-70
-3% -$22.1K 0.03% 446
2022
Q4
$581K Sell
2,013
-212
-10% -$61.2K 0.04% 443
2022
Q3
$644K Buy
+2,225
New +$644K 0.05% 384
2022
Q2
Sell
-1,838
Closed -$480K 810
2022
Q1
$480K Sell
1,838
-2,428
-57% -$634K 0.04% 421
2021
Q4
$937K Sell
4,266
-522
-11% -$115K 0.07% 277
2021
Q3
$868K Sell
4,788
-1,459
-23% -$264K 0.07% 275
2021
Q2
$1.26M Buy
6,247
+619
+11% +$125K 0.08% 271
2021
Q1
$1.21M Buy
5,628
+556
+11% +$119K 0.09% 239
2020
Q4
$1.2M Buy
5,072
+2,429
+92% +$574K 0.1% 213
2020
Q3
$719K Sell
2,643
-1,817
-41% -$494K 0.07% 261
2020
Q2
$1.3M Buy
4,460
+2,129
+91% +$618K 0.18% 127
2020
Q1
$555K Buy
2,331
+1,158
+99% +$276K 0.08% 270
2019
Q4
$257K Sell
1,173
-219
-16% -$48K 0.03% 493
2019
Q3
$236K Buy
1,392
+202
+17% +$34.2K 0.03% 492
2019
Q2
$218K Buy
+1,190
New +$218K 0.03% 473
2018
Q2
Sell
-117
Closed -$18K 1353
2018
Q1
$18K Hold
117
﹤0.01% 1021
2017
Q4
$18K Buy
117
+80
+216% +$12.3K ﹤0.01% 1022
2017
Q3
$6K Buy
+37
New +$6K ﹤0.01% 1074